- Home
- EH vs SYRE Comparison
EH vs SYRE Comparison
Compare EH & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EH
- SYRE
- Stock Information
- Founded
- EH 2014
- SYRE 2013
- Country
- EH China
- SYRE United States
- Employees
- EH N/A
- SYRE N/A
- Industry
- EH Military/Government/Technical
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- EH Industrials
- SYRE Health Care
- Exchange
- EH Nasdaq
- SYRE Nasdaq
- Market Cap
- EH 1.1B
- SYRE 1.1B
- IPO Year
- EH 2019
- SYRE 2016
- Fundamental
- Price
- EH $16.91
- SYRE $15.21
- Analyst Decision
- EH Strong Buy
- SYRE Strong Buy
- Analyst Count
- EH 3
- SYRE 5
- Target Price
- EH $24.80
- SYRE $61.25
- AVG Volume (30 Days)
- EH 2.1M
- SYRE 492.5K
- Earning Date
- EH 08-26-2025
- SYRE 11-06-2025
- Dividend Yield
- EH N/A
- SYRE N/A
- EPS Growth
- EH N/A
- SYRE N/A
- EPS
- EH N/A
- SYRE N/A
- Revenue
- EH $65,001,814.00
- SYRE N/A
- Revenue This Year
- EH $102.39
- SYRE N/A
- Revenue Next Year
- EH $59.66
- SYRE N/A
- P/E Ratio
- EH N/A
- SYRE N/A
- Revenue Growth
- EH 87.04
- SYRE N/A
- 52 Week Low
- EH $11.70
- SYRE $10.91
- 52 Week High
- EH $29.76
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- EH 51.09
- SYRE 39.66
- Support Level
- EH $16.72
- SYRE $14.67
- Resistance Level
- EH $17.40
- SYRE $17.58
- Average True Range (ATR)
- EH 0.62
- SYRE 0.73
- MACD
- EH 0.14
- SYRE -0.21
- Stochastic Oscillator
- EH 75.82
- SYRE 18.70
About EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.